Skip to Content
🌐Ship toSelect country

Neauvia Stimulate - 1 x 1,0ml

Neauvia Stimulate is a dual-action filler from Matex Lab's Neauvia range, combining PEG-cross-linked hyaluronic acid (26mg/ml) with 1% calcium hydroxyapatite (CaHA) microparticles plus glycine and L-proline. It provides immediate volumisation of deep wrinkles and nasolabial folds alongside longer-term biostimulation, as CaHA encourages neocollagenesis for gradual improvement in skin density and firmness. Injected into the subdermis and/or over the periosteum; filling effects last around 6 months, with biostimulatory skin-quality improvements extending beyond that. CE Class III medical device. For use by licensed, trained medical professionals only.

57.00 € 57.00 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Biostimulators Brand Neauvia
SKU A3008 Share
Treatment Areas ChinFaceNasolabial folds
Tags Non-Animal Origin

Neauvia Stimulate is a biostimulatory injectable from Matex Lab, combining hyaluronic acid with calcium hydroxyapatite (CaHA) microparticles to encourage the skin's own collagen production while providing structural support. It works progressively over several weeks rather than through immediate volumising effect alone.

CONCENTRATION

  • Hyaluronic acid with calcium hydroxyapatite (CaHA) microparticles

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results build progressively over several weeks; typically last 9-12 months.

INDICATIONS

  • Loss of facial structure and firmness
  • Early to moderate signs of ageing

TREATMENT AREAS

  • Face, general
  • Cheeks

Neauvia Stimulate is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

A course of 2-3 sessions is typically recommended, with maintenance treatments every 9-12 months.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin